HIV Infections: all 4,340 studies
Page 7 of 44. Open to participants first (240), then studies with results posted, then the rest; newest registration first within each.
- ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor TreatmentCompletedNCT02735863Phase 2Results posted
- Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With MenCompletedNCT02720094Phase 2/3Results posted
- Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045)CompletedNCT02715700Phase 1Results posted
- Nurse Case Management to Improve Hepatitis C Care in HIV Co-infectionCompletedNCT02707991Not applicableResults posted
- Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV InfectionCompletedNCT02664415Phase 2Results posted
- Improving Prognosis in HIV InfectionCompletedNCT02640625Phase 1/2Results posted
- The Compartmental Biology of HIV in the Male Genital TractCompletedNCT02638493Results posted
- A Phase IV, Open Label, 4-period Cross-over Study to Investigate a Drug Interaction Between Lamivudine and Sorbitol Oral Solutions in Healthy VolunteersCompletedNCT02634073Phase 4Results posted
- Cardiometabolic Effects of Eplerenone in HIV InfectionTerminatedNCT02629094Phase 2Results posted
- Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection.CompletedNCT02625909Phase 3Results posted
- Inflammatory Pathogenesis of Coronary Atherosclerosis in HIVCompletedNCT02624180Phase 2Results posted
- Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCVCompletedNCT02600325Phase 3Results posted
- Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV InfectionCompletedNCT02591420Phase 1Results posted
- A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) InfectionCompletedNCT02582983Phase 4Results posted
- Targeting Platelets in Chronic HIV InfectionCompletedNCT02578706Phase 2Results posted
- Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American MenCompletedNCT02572401Not applicableResults posted
- Bioavailability of Doravirine (MK-1439) Experimental Nano Formulations in Healthy Adults (MK-1439-046)CompletedNCT02549040Phase 1Results posted
- Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation StudyTerminatedNCT02531295Phase 1Results posted
- Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)CompletedNCT02519777Phase 4Results posted
- Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIVCompletedNCT02495779Not applicableResults posted
- Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 CoinfectionCompletedNCT02480712Phase 3Results posted
- Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine RegimenCompletedNCT02478632Phase 3Results posted
- Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult VolunteersCompletedNCT02478463Phase 1Results posted
- Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected AdultsCompletedNCT02475655Phase 2Results posted
- Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected Children and Young AdultsCompletedNCT02474901Phase 2Results posted
- The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824)CompletedNCT02473367Phase 1Results posted
- Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral TherapyCompletedNCT02471430Phase 1/2Results posted
- VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment InterruptionCompletedNCT02471326Phase 1Results posted
- Evaluating the Safety, Pharmacokinetics, and Antiviral Activity of a Human Monoclonal Antibody (VRC01) in HIV-Infected Adults Undergoing a Brief Treatment InterruptionCompletedNCT02463227Phase 1Results posted
- Optimizing Smoking Cessation for People With HIV/AIDS Who SmokeCompletedNCT02460900Phase 3Results posted
- Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-InfectionCompletedNCT02457611Phase 2Results posted
- Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy WomenCompletedNCT02431273Early Phase 1Results posted
- Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)CompletedNCT02429791Phase 3Results posted
- Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)CompletedNCT02422797Phase 3Results posted
- Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive AdultsTerminatedNCT02415595Phase 2Results posted
- Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)CompletedNCT02411539Phase 1Results posted
- Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryTerminatedNCT02408861Phase 1Results posted
- A Safety and Immune Response Study of 2 Experimental HIV VaccinesCompletedNCT02404311Phase 1/2Results posted
- Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021)CompletedNCT02403674Phase 3Results posted
- CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeSCompletedNCT02402218Not applicableResults posted
- Mobile Strategies for Women's and Children's Health: Optimizing Adherence and Efficacy of PMTCT/ARTCompletedNCT02400671Not applicableResults posted
- Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced AdultsTerminatedNCT02386098Phase 2Results posted
- Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV InfectionCompletedNCT02384395Not applicableResults posted
- Attachment Inhibitor Comparison in Heavily Treatment Experienced PatientsActive, not recruitingNCT02362503Phase 3Results posted
- Glutathione and Function in HIV PatientsCompletedNCT02348775Phase 1Results posted
- Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)CompletedNCT02282293Phase 3Results posted
- Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected ParticipantsCompletedNCT02269917Phase 3Results posted
- Economic and Social Empowerment To Increase Upwards Mobility Among WomenCompletedNCT02266108Not applicableResults posted
- Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug ExposureCompletedNCT02263326Phase 3Results posted
- ODYSSEY (PENTA 20)CompletedNCT02259127Phase 2/3Results posted
- Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed InfantsCompletedNCT02256631Phase 1Results posted
- Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line TreatmentCompletedNCT02227238Phase 3Results posted
- Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAARTCompletedNCT02225665Phase 1/2Results posted
- Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive AdultsCompletedNCT02218320Results posted
- Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in AdolescentsCompletedNCT02213328Phase 2Results posted
- Tesamorelin Effects on Liver Fat and Histology in HIVCompletedNCT02196831Not applicableResults posted
- Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected AdultsCompletedNCT02178800Phase 2Results posted
- Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infectionCompletedNCT02178592Phase 3Results posted
- Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 InfectionCompletedNCT02175680Phase 2Results posted
- Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure ProphylaxisCompletedNCT02165202Phase 2Results posted
- Efficacy and Safety Study of Darunavir for the Treatment of HIV/AIDSCompletedNCT02155101Phase 3Results posted
- CASA: Care and Support Access in HIV DiseaseCompletedNCT02136680Not applicableResults posted
- Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)CompletedNCT02131233Phase 3Results posted
- Effect of Cenicriviroc on HIV Neurocognitive ImpairmentCompletedNCT02128828Phase 2Results posted
- Dipyridamole for Immune Activation in HIVCompletedNCT02121756Phase 1/2Results posted
- A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult SubjectsCompletedNCT02120352Phase 2Results posted
- A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral RegimenCompletedNCT02105987Phase 3Results posted
- An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected PatientsCompletedNCT02103439Phase 3Results posted
- Fish Oil for HIV-Related Inflamm-aging and Immune SenescenceCompletedNCT02102724Not applicableResults posted
- Changes in Lipids and Lipoproteins in HIV Infected Women After Switch From Protease Inhibitor to RaltegravirCompletedNCT02097108Phase 2Results posted
- Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention StudyCompletedNCT02081638Phase 2Results posted
- Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)CompletedNCT02076178Phase 2Results posted
- ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus InfectionCompletedNCT02075593Phase 3Results posted
- Enhancement by Poly-ICLC During HIV-1 InfectionCompletedNCT02071095Phase 1/2Results posted
- Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP)CompletedNCT02067039Not applicableResults posted
- Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)CompletedNCT02063880Not applicableResults posted
- Early Versus Delayed BCG Vaccination of HIV-exposed InfantsCompletedNCT02062580Phase 2Results posted
- Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin LesionsCompletedNCT02059499Phase 3Results posted
- AIDS 347: IL-6 Blockade in Treated HIV InfectionCompletedNCT02049437Phase 1/2Results posted
- Effect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive PatientsCompletedNCT02041520Phase 3Results posted
- Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV InfectionCompletedNCT02038881Phase 2Results posted
- Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy VolunteersCompletedNCT02038842Phase 1/2Results posted
- Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in AfricaCompletedNCT02028676Phase 4Results posted
- Study of Dapivirine Vaginal Ring (VR) in AdolescentsCompletedNCT02028338Phase 2Results posted
- Quantifying Drug Adherence and Drug Exposure to Antiretroviral TherapyCompletedNCT02012621Results posted
- Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal WomenCompletedNCT02010593Phase 2Results posted
- Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive AdultsCompletedNCT01968551Phase 3Results posted
- Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced AdultsCompletedNCT01967940Phase 3Results posted
- The Safety and Immunogenicity of a Potential HIV VaccineCompletedNCT01966900Phase 1Results posted
- Real-Time Antiretroviral Therapy Adherence Intervention in UgandaCompletedNCT01957865Not applicableResults posted
- Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV MedicationsCompletedNCT01949116Phase 2Results posted
- Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation StudyCompletedNCT01944371Phase 1/2Results posted
- A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 CoinfectionCompletedNCT01939197Phase 2/3Results posted
- Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral LoadCompletedNCT01933594Phase 1/2Results posted
- A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295)CompletedNCT01930045Phase 1Results posted
- Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based RegimenCompletedNCT01929759Not applicableResults posted
- Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric ParticipantsTerminatedNCT01923311Phase 2/3Results posted
- Dutch Acute HCV in HIV Study (DAHHS)CompletedNCT01912495Phase 2Results posted
- A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)CompletedNCT01910402Phase 3Results posted
- Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ARTCompletedNCT01869634Phase 4Results posted